PTPA and cancer: Furthermore, the recent reports of small molecules and peptides that are capable of restoring the PP2A activity in human cancer cell lines provide convincing support to this strategy to be used as cancer therapeutics (Perrotti and Neviani, 2013; Farrell et al., 2014).